We have two very exciting upcoming presentations by @GreggWStone at #TCT2025 - including the first ever reveal of the results from our initial clinical trial. Check this out if you can!
302
The Adona team will be on-site this weekend in Minneapolis for HFSA ASM 2025!! Definitely reach-out if you’d like to connect! #HFSA2025
1
374
Leveraging A.I. for adaptive, precision medicine.
Last week our CEO Brian Fahey was on a panel at the Octane Cardiovascular Forum, and got to share a bit about where we think we're headed for the future of device-based heart failure management
223
an announcement we’re quite proud of: all patients from our initial study are now in the follow-up period, with a majority having undergone successful planned secondary interventions at 90 days. Link to more info in the comments below:
1
154
It was exciting to see @GreggWStone present the latest from our early clinical trials during #CRT2025! Each month brings more progress!
2
124
This week Adona successfully completed another round of clinical cases. We’d like to thank our clinical partners, including our US-based MDs who joined this trip (@HamidNadira, @LiviuKlein, @GaganSHDoc, @psorajja, and @ManiVannanheart) who worked with support from @mryburns.
Today we were very fortunate to have @LiviuKlein present the latest from Adona at the #THT2025 conference! The talk included some novel results including what might be the first ever case study acute hemodynamic changes with different shunt flows in the same patient @crfheart
1
3
311
This is fantastic and a big leap forward. The next step of course is evidence-based guidelines for how to use this information to impact outcomes. Identifying high risk is only worthwhile if the information is actionable!
Study led by CarDS Lab postdoc @LovedeepDhingra releases our new #AI tool that can identify individuals at high risk of developing HF using ECG images.
Read more: medicine.yale.edu/news-artic…
1
76
Adona Medical retweeted
“Solely applying a P value threshold or 95% CI to determine if a treatment works or not is an [often misleading] oversimplification.”
How do we make sense of two “negative” trials in @NEJM and a “positive” meta-analysis of the two trials in NEJM Evidence? @emil_hs and @FralickMike share some insights in this editorial: eviden.cc/3OYutgJ
Adona Medical retweeted
Heart failure has come to the fore as an innovation and acquisition target for #MedTech companies at a time when the Heart Failure Society is working to create guidelines that support the use of devices in many groups of #heartfailure patients: bit.ly/3AuxtOe
Listen to Dr. @GreggWStone discuss the Adona technology during a recent @CSIcongress webinar moderated by Dr. Marat Fudim @FudimMarat
1
2
172
Adona Medical retweeted
"Explore Devices for Many-Faceted Heart Failure" by @MaryStuartMTS featuring key innovations in #heartfailure treatment.
Dive into the main article & three deep dives from @Acorai_Official, @AdonaMedical, & @corinnova. Read more: bit.ly/3AuxtOe #MedTech
It’s been a productive TCT so far for the Adona team. Lots of great booth conversations, important physician meetings, and a fantastic presentation by Dr Gagan Singh at our well-attended educational event. More to come!
54
Adona Medical retweeted
.@AdonaMedical Debuts Interatrial Shunt for Heart Failure
Adona’s new interatrial shunt with adjustable blood flow and real-time monitoring shows promise for personalized heart failure care.
Read: newzchain.com/adona-medical-…
#Newzchain #Adonamedical #Medicaldevice
We're thrilled to share the news of our initial clinical cases! Much left to do, but we're excited for the road ahead. Many thanks to @GaganSHDoc, @psorajja, @LiviuKlein, @FudimMarat, @GreggWStone, and all the other collaborators who made this possible!
prnewswire.com/news-releases…
1
1
161
The Adona team will be at the @TCTConference starting on Sunday. Swing by the @shifamed booth (#1024) or reach out to a team member to say hello! @TCTMD
43
























